Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05133362 · ClinicalTrials.gov registry record · NA
Effects of Backward Gait Training With Exoskeleton on Motor Functions
A NA study, sponsored by Alvernia University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT05133362 is a NA study that was terminated before completion, run by Alvernia University. The registered enrollment target is 9 participants.
The verdict
NCT05133362, a NA study, was terminated before completion, sponsored by Alvernia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The proposed study aims to optimize patient outcomes and treatment intervention using a robotic exoskeleton in adults with cerebrovascular accidents (CVA, stroke) by investigating the following: AIM 1 is to investigate the effect of backward gait training with exoskeleton on motor function. AIM 2 is to investigate the effect of backward gait training with exoskeleton on depression. AIM 3 is to investigate the impact of social determinants of health and depression on patient adherence to physical therapy.
Interventions
- DEVICE Gait training with EksoNR
- PROCEDURE Backward gait training with EksoNR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-08-25 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05133362
The ClinicalTrials.gov registry entry for NCT05133362 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alvernia University, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gait training with EksoNR is the first listed.
NCT05133362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05133362 about?
NCT05133362 is a clinical study titled "Effects of Backward Gait Training With Exoskeleton on Motor Functions". The proposed study aims to optimize patient outcomes and treatment intervention using a robotic exoskeleton in adults with cerebrovascular accidents (CVA, stroke) by investigating the following: AIM 1 is to investigate the effect of backward gait training with exoskeleton on motor function. AIM 2 i...
What is the current status of trial NCT05133362?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2022-08-25. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT05133362?
The interventions under investigation include: Gait training with EksoNR (DEVICE), Backward gait training with EksoNR (PROCEDURE).
Who is sponsoring clinical trial NCT05133362?
This trial is sponsored by Alvernia University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.